Arestat™ comprises two fundamentally different aspects of our platform stabilization technology. Both utilize excipients and buffers approved by the FDA and EMEA in an unconventional manner to achieve the desired stability.

Both platform technologies are available for licensing for applications involving therapeutic proteins, vaccines, medical devices and diagnostics.